Key result
A narrative review highlights the need to establish consensus guidelines for the multimodal treatment of malignant bowel obstruction caused by peritoneal carcinomatosis.
Why the study?
Malignant bowel obstruction from peritoneal carcinomatosis is a common complication with poor survival, but selecting the optimal treatment strategy remains unclear.
There is a critical need for consensus guidelines to direct the multimodal management of malignant bowel obstruction in patients with peritoneal carcinomatosis.
Does not yet alter practice for peritoneal carcinomatosis-related obstruction; leaves open optimal multimodal strategies pending consensus guidelines.
Malignant bowel obstruction caused by peritoneal carcinomatosis is a common complication that affects a large proportion of gastrointestinal and ovarian oncology patients and predicts poor longterm survival. The management strategy for these patients includes a variety of medical therapies and surgical options; however, how to choose the best treatment strategy remains a mystery. The purpose of this narrative review was to summarize the most recent evidence on multimodal malignant bowel obstruction treatment and determine whether or not progress had been made. We should work to establish consensus guidelines, where possible, to ensure that this unique patient group receives the appropriate treatment or compassionate care during this often terminal event.
No takes yet. Share an insight, caveat, or question.
Nardecchia et al. (2023) conducted a review in Malignant bowel obstruction caused by peritoneal carcinomatosis. Multimodal malignant bowel obstruction treatment was evaluated. A narrative review highlights the need to establish consensus guidelines for the multimodal treatment of malignant bowel obstruction caused by peritoneal carcinomatosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: